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Abstract
Plasmacytoid dendritic cells (pDC) are essential innate immune system cells that are lost from the circulation in human
immunodeficiency virus (HIV)–infected individuals associated with CD4+ T cell decline and disease progression. pDC
depletion is thought to be caused by migration to tissues or cell death, although few studies have addressed this directly.
We used precise methods of enumeration and in vivo labeling with 5-bromo-29-deoxyuridine to track recently divided pDC
in blood and tissue compartments of monkeys with acute pathogenic simian immunodeficiency virus (SIV) infection. We
show that pDC are lost from blood and peripheral lymph nodes within 14 days of infection, despite a normal frequency of
pDC in bone marrow. Paradoxically, pDC loss masked a highly dynamic response characterized by rapid pDC mobilization
into blood and a 10- to 20-fold increase in recruitment to lymph nodes relative to uninfected animals. Within lymph nodes,
pDC had increased levels of apoptosis and necrosis, were uniformly activated, and were infected at frequencies similar to
CD4+ T cells. Nevertheless, remaining pDC had essentially normal functional responses to stimulation through Toll-like
receptor 7, with half of lymph node pDC producing both TNF-a and IFN-a. These findings reveal that cell migration and
death both contribute to pDC depletion in acute SIV infection. We propose that the rapid recruitment of pDC to inflamed
lymph nodes in lentivirus infection has a pathologic consequence, bringing cells into close contact with virus, virus-infected
cells, and pro-apoptotic factors leading to pDC death.
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Introduction
Plasmacytoid dendritic cells (pDC) are important in bridging
innate and adaptive immune responses to pathogens [1–3]. pDC
derive from bone marrow and are recruited into lymph nodes in
response to inflammation, producing type I interferon (IFN) and
contributing to the generation of virus-specific T cell responses [2–
5]. Human immunodeficiency virus (HIV) infection of humans
and simian immunodeficiency virus (SIV) infection of monkeys
result in pDC loss from blood that is correlated with high viral load
and reduced numbers of CD4+ T cells [6–16]. pDC-derived type I
IFN limits HIV replication in CD4+ T cells [17–19] and
frequencies of pDC are higher in HIV-infected long-term non-
progressors than healthy donors [20], suggesting that diminished
pDC numbers likely contribute to the lack of immune control in
this disease. However, the mechanism of pDC loss in HIV
infection has not been defined.
A central hypothesis accounting for pDC depletion from blood
during HIV infection is recruitment to inflamed lymphoid tissues
[18,21]. Evidence for pDC recruitment comes from the finding
that pDC exposed to HIV express the chemokine receptor CCR7
required for homing to lymph node paracortex [21], and recent
data in rhesus macaques confirm that CCR7 is induced on
circulating pDC in response to pathogenic SIV infection [22].
Moreover, expression of CXCL9 is highly upregulated in
lymphoid tissues in acute SIV infection [23,24], and pDC enter
lymph nodes in a CXCL9-dependent manner [4]. However, there
is also substantial evidence to support a role for cell death in pDC
loss in HIV infection. HIV infects pDC both in vitro and in vivo and
induces cytopathic effects and death following maturation [25–29].
In addition, pDC from HIV-infected individuals undergo death by
apoptosis and necrosis following interaction and fusion with HIV-
infected cells [17]. The relative contribution of recruitment to
tissues and cell death to pDC loss in HIV infection remains to be
determined.
To tease out the different potential mechanisms of pDC loss, we
studied kinetics of the pDC response during acute infection of
rhesus macaques with the pathogenic SIV strain SIVmac251. We
enumerated pDC in different compartments and used in vivo
labeling with the thymidine analogue 5-bromo-29-deoxyuridine
(BrdU) together with Ki-67 staining to document mobilization and
recruitment of recently divided cells that would otherwise be
obscured by net cell loss. We find that pDC are lost from blood
and peripheral lymph nodes early in SIV infection despite massive
mobilization and recruitment, associated with pDC activation,
infection and death in lymph nodes. These findings demonstrate
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that pDC recruitment and killing work together in the context of
the lymph node to bring about pDC depletion in SIV infection.
Results
Rapid loss of pDC from blood and lymph node during
acute SIV infection
In order to document changes in pDC number in blood during
HIV infection, we used the rhesus macaque model of intravenous
infection with the pathogenic isolate SIVmac251. Infection
resulted in detectable viremia within 3 days of infection that
plateaued at day 12 and was associated with an expected decline in
the number of blood CD4+ T cells by day 10 (Figure S1). pDC
were identified within the CD45+ mononuclear cell fraction of
peripheral blood leukocytes (PBL) as Lineage (CD3, CD14,
CD20)2 HLA-DR+ CD123+ cells using flow cytometry
(Figure 1A) [13]. pDC determinations were made by multiplying
the percentage of pDC in this CD45+ mononuclear cell fraction by
the absolute number of CD45+ mononuclear cells in whole blood
determined using TruCOUNT tubes [30]. In contrast to CD4+ T
cells, there was a significant increase in the number of blood pDC
between 3 and 6 days post infection, in some instances reaching 7
times that of pre-infection levels, indicative of peracute mobiliza-
tion of pDC (Figure 1B). This was followed at day 10 by a
significant decrease in pDC number from baseline which
remained suppressed until at least day 14 (Figure 1B), when
CD4+ T cells had begun to recover (Figure S1). The absolute
number of pDC in blood was inversely correlated with plasma
viral load and positively correlated with CD4+ T cell number
during the course of primary SIV infection (Figure 1C). To
determine whether the drop in pDC from blood at days 10–14 of
infection was associated with an increase in pDC number in lymph
nodes, we harvested axillary lymph nodes prior to and 14 days
after infection and determined the proportion and absolute
number of pDC in cell suspensions. pDC were identified as
CD123+ cells within the Lineage2 HLA-DR+ fraction following
exclusion of dead cells based upon staining with an amine-reactive
viability dye. This gate excludes the majority of myeloid DC
(mDC) which express high levels of HLA-DR and have significant
autofluorescence that places them above the Lineage+ HLA-DR+
population (Figure 1D) [13]. Surprisingly, the percentage of live
pDC within the Lineage2 HLA-DR+ gate decreased significantly
from a median of 32% prior to infection to 7% at day 14 post
infection (Figure 1E). Similarly, the absolute number of live pDC
decreased by more than 65% from a pre-infection median of
2.36106 cells/g to a post infection median of 0.86106 cells/g
(Figure 1E). This decrease was not offset by lymph node
hyperplasia as the total cellularity of lymph nodes actually
decreased significantly in response to infection, from a median
of 5.56108 cells/g (range 3.76108 to 8.36108) to 3.36108 cells/g
(range 2.46108 to 4.36108; P = 0.04 by Mann-Whitney U test).
This loss in cellularity is likely the combined effect of tissue edema
and CD4+ T cell depletion [31]. These findings indicate that acute
SIV infection results in a bimodal pDC response in blood, with
rapid pDC increases followed by loss, and that this loss is
paralleled by depletion of pDC from lymph nodes.
Acute SIV infection does not alter the frequency of pDC
in bone marrow
The depletion of pDC from both blood and lymph nodes during
acute SIV infection could be explained by bone marrow
suppression leading to a loss of pDC production. To address this
possibility we analyzed the frequency of phenotypically-defined
pDC in paired bone marrow samples taken prior to and 12 days
following SIV infection. pDC were identified within the Lineage2
HLA-DR+ fraction of bone marrow mononuclear cells by
expression of CD123 (Figure 2A), as has previously been described
[32]. There was inherent variability in the samples collected from
bone marrow as the total number of mononuclear cells and the
proportion and number of pDC varied widely between animals.
However, there was no significant difference in these parameters
prior to and after infection when animals were compared as a
group (Figure 2B). We next analyzed bone marrow pDC for
expression of the nuclear proliferation antigen Ki-67, which is
expressed by cells in a non-G0 phase of the cell cycle and thus
provides an approximation of the recent proliferative history of a
given cell population [33]. The majority of bone marrow pDC in
SIV-naı¨ve animals were Ki-67+ reflecting a high rate of
production [5] and this was unchanged as a result of SIV infection
(Figure 2C). These data indicate that acute SIV infection does not
significantly alter pDC production or dynamics in bone marrow.
Rapid mobilization of pDC into blood during acute SIV
infection
The rapid but transient increase in the number of pDC in blood
together with normal pDC frequencies in bone marrow raised the
possibility that pDC were being actively mobilized from bone
marrow into blood during acute SIV infection. To measure pDC
mobilization directly we again turned to markers of cell division,
based on findings in the mouse that pDC do not undergo
proliferation in peripheral tissues under physiologic conditions [5].
We first needed to confirm that pDC in the rhesus macaque had
the same characteristics, especially given that exposure to SIV can
induce marked pDC activation [16,22] that conceivably could
result in cell division. To address this we stimulated normal
macaque peripheral blood mononuclear cells (PBMC) with 3M-
007, an agonist of Toll-like receptor (TLR)7/8, as viral RNA
stimulates pDC largely through TLR7 engagement [22,34]. Cells
were then pulsed with BrdU and pDC analyzed by flow cytometry
for BrdU incorporation. No BrdU incorporation was detected
indicating that pDC were not induced to enter S-phase of the cell
cycle following in vitro activation (Figure S2). pDC are likely to be
exposed to a wide range of microbial and inflammatory stimuli in
addition to viral RNA as a consequence of SIV infection [35]. To
Author Summary
Plasmacytoid dendritic cells (pDC) are essential compo-
nents of the innate immune system whose loss from blood
is associated with disease progression in human immuno-
deficiency virus–infected individuals. The mechanism of
pDC loss is undefined but is believed to be associated with
migration to tissues or cell death. To address this question,
we studied pDC kinetics in blood and tissues in the related
rhesus macaque monkey model of simian immunodefi-
ciency virus infection. We found that pDC were present in
normal numbers in bone marrow but were lost from blood
and lymph nodes within 14 days of intravenous infection.
Underlying pDC loss was a profound mobilization of pDC
from bone marrow into blood and subsequent influx into
lymph nodes. In lymph nodes pDC were activated,
apoptotic, and frequently infected with virus. Nevertheless,
pDC were functionally normal with respect to cytokine
production. We conclude that migration and death both
contribute to pDC depletion, with influx into lymph nodes
bringing cells into an environment favoring their death by
infection or apoptosis.
Plasmacytoid DC Loss in SIV Infection
PLoS Pathogens | www.plospathogens.org 2 May 2009 | Volume 5 | Issue 5 | e1000413
Figure 1. pDC are transiently increased and then lost from blood and lymph nodes in acute SIV infection. (A) Representative contour
plots demonstrating the gating strategy used to define pDC within the mononuclear cell fraction (MNC) of freshly isolated peripheral blood
leukocytes. (B) Absolute number of pDC in blood during acute SIV infection over all days (left) and comparing pre-infection to peak responses at day
3 or 6 (right). Symbols represent individual animals with the baseline number of pDC/mL blood prior to infection (day 0) representing the median of 4
independent measurements for each animal. (C) The number of pDC in blood was inversely correlated with viral load and positively correlated with
CD4+ T cell counts during the 14-day period. (D) Representative plots demonstrating the gating strategy used to delineate the Lineage2 HLA-DR+
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determine whether such in vivo activation results in pDC
proliferation we incubated lymph node cells harvested from a
rhesus macaque 14 days after SIVmac251 infection with BrdU
and examined cells for BrdU incorporation. There was no
detectable BrdU incorporation by pDC, indicating lack of cell
division (Figure S2). In contrast, 15% of lymph node mDC
incorporated BrdU (Figure S2), consistent with findings in the
mouse that mDC undergo proliferation in lymphoid tissues [5].
These findings confirm that rhesus macaque pDC do not undergo
detectable proliferation in the blood or lymph node compartments
either in health or during acute SIV infection. Using this
information, we then analyzed blood pDC from our cohort of
Figure 2. Normal frequency of pDC in bone marrow in acute SIV infection. (A) Representative contour plots demonstrating the gating
strategy used to define pDC within the mononuclear cell (MNC) fraction of bone marrow aspirates. (B) Paired analyses of the absolute number of MNC
in bone marrow (left), the frequency of pDC within the total MNC fraction (middle) and the absolute number of pDC in bone marrow (right) before
and 12 days after SIV infection. Symbols represent individual animals. (C) Left: pDC were gated as in (A) and the percentage of pDC expressing Ki-67
determined by comparing to staining with an isotype control Ab. Contour plots represent an analysis at day 12 post infection and numbers represent
the percentage of cells within the indicated gates. Right: Paired analysis of the percentage of Ki-67+ pDC before infection and at day 12 post-
infection. NS = not significant.
doi:10.1371/journal.ppat.1000413.g002
cells and CD123+ pDC in axillary lymph node cell suspensions. (E) Number of live pDC in lymph nodes of naı¨ve animals and animals at 14 days post-
infection expressed as percent of pDC within the Lineage2 HLA-DR+ fraction (left) and as absolute number of pDC/g of tissue (right). Symbols
represent individual animals and horizontal lines represent medians.
doi:10.1371/journal.ppat.1000413.g001
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animals for expression of Ki-67, which would provide an
indication of the pDC fraction that was recently mobilized. Prior
to SIV infection, the mean percentage of Ki-67+ pDC was 52%
(Figure 3A and 3B), indicating that half of all pDC in the
circulation were recently released from bone marrow. However,
by day 14 post infection 87% of circulating pDC expressed Ki-67
indicative of mobilization (Figure 3B), and this increase was
inversely correlated with the absolute number of blood pDC
(Figure 3C). To accurately determine the rate of mobilization of
pDC into blood we administered BrdU by intravenous injection at
days 10, 11, 12 and 13 post infection and sampled blood 24 hours
after each administration. Any BrdU+ pDC in blood would be
marked as having been released from bone marrow since the time
of the BrdU pulse. In SIV-naı¨ve monkeys only 2% of blood pDC
were BrdU+ at 24 hours after the first pulse, reaching a maximum
of 13% after the fourth pulse, indicating a relatively low rate of
pDC mobilization in health (Figure 3D and 3E). In stark contrast,
upwards of 20% of blood pDC from SIV-infected animals at day
11 were BrdU+ after a single BrdU pulse and this approached 60%
after the fourth pulse at day 14 post infection (Figure 3D and 3E).
The degree of Ki-67 staining and BrdU incorporation at day 14
were strongly correlated (Figure 3F). These findings indicate that
by day 10 post infection rhesus macaques had a profound
mobilization of pDC from bone marrow that was effectively
masked by declining cell numbers in blood.
Massive recruitment of pDC into peripheral lymph nodes
during acute SIV infection
We next used BrdU incorporation and Ki-67 staining to
investigate whether increased mobilization of pDC into blood was
paralleled by recruitment of pDC to lymph nodes, despite the loss
of pDC from these tissues. Axillary lymph nodes were harvested
from SIV-infected monkeys at day 14 post infection and from SIV-
naı¨ve monkeys receiving the same course of BrdU and pDC were
analyzed for BrdU incorporation (Figure 4A). Only 2% of lymph
node pDC were BrdU+ after 4 pulses of BrdU in SIV-naı¨ve
monkeys, indicating a low level of pDC recruitment into normal
lymph nodes. However, 19% of lymph node pDC from SIV-
infected monkeys were BrdU+, representing a,10-fold increase in
pDC recruitment over the 4-day labeling period relative to
controls (Figure 4B). Strikingly, the mean proportion of lymph
node pDC that were Ki-67+ in SIV-naı¨ve monkeys was only 2.5%,
whereas more than 50% of lymph node pDC from monkeys at day
14 post infection stained for Ki-67. This represents a 20-fold
increase in recently-divided pDC within lymph nodes as a result of
SIV infection (Figure 4C and 4D). In fact, whereas the total
number of lymph node pDC declined in acute SIV infection
(Figure 1E) the number of Ki-67+ pDC in lymph nodes was
significantly increased over SIV-naı¨ve lymph nodes (Figure 4D).
Nevertheless, the proportion of pDC that expressed Ki-67 had a
strong inverse correlation with the total number of pDC in lymph
nodes, indicating that recruitment and loss were occurring
concurrently (Figure 4E). Together, these data demonstrate that
pDC undergo a marked recruitment to peripheral lymph nodes
during acute SIV infection but that the net result is an overall loss
of pDC from these tissues.
Activation, infection, and death of pDC in lymph nodes
during acute SIV infection
The overall loss of pDC from lymph nodes despite their massive
recruitment strongly suggests that pDC are dying in these tissues
during infection. To examine this directly, we first stained lymph
node cell suspensions with antibodies to define pDC and then
measured the proportion of cells that were dead based on staining
with the amine-reactive viability dye. Nearly 15% of pDC from
lymph nodes taken at 14 days post infection were non-viable as
compared to 3% of pDC from naı¨ve lymph nodes (Figure 5A).
This increase was due to an increase in late apoptosis and/or
necrosis based on pDC co-labeling with Annexin V and 7-AAD
(Figure 5B). These data indicate that pDC resident in lymph nodes
are more likely to be apoptotic or necrotic as a result of acute SIV
infection. To determine whether direct virus infection could play a
role in pDC death, we stained lymph node cell suspensions with
antibodies and simultaneously sorted pDC as Live/Dead2
Lineage2 HLA-DR+ CD123+ CD11c2 cells and mDC as Live/
Dead2 Lineage2 HLA-DR++ CD1232 CD11c+ [13] to at least
95% purity (Figure 5C). SIV gag DNA was then measured in total
cellular DNA from these cells using gag primers and probe by
quantitative PCR and the frequency of infected cells determined
on the basis of albumin DNA quantity, as described in the Methods
section [31]. In separate tubes we sorted CD4+ T cells as Live/
Dead2 CD3+ CD4+ CD82 cells and determined their frequency
of SIV infection. These data revealed that more than 4% of lymph
node pDC harbored SIV gag DNA at day 14, reaching up to 15%
in one animal, a frequency that was slightly greater than SIV-
infected CD4+ T cells and well above that of the unseparated
lymph node fraction (Figure 5C). In contrast, mDC had almost
undetectable levels of gag DNA (Figure 5C). The negligible
infection of mDC confirms that the pDC result was not due to
contaminating CD4+ T cells, as mDC and pDC were sorted
simultaneously from the same tubes. To investigate whether
indirect mechanisms of pDC death may also contribute to the
significant cell death seen in lymph nodes, we measured expression
of known pro-apoptotic tumor necrosis factor (TNF) family
members CD95 (Fas), TNF-related apoptosis-inducing ligand
(TRAIL) and the TRAIL receptor death receptor (DR) 5 by flow
cytometry. These data revealed that lymph node pDC from SIV-
naı¨ve monkeys had almost undetectable expression of CD95,
whereas CD95 was uniformly expressed by pDC from SIV-
infected lymph nodes, indicative of activation [36] (Figure 5D).
However, we were not able to detect differences in apoptosis of
lymph node pDC from uninfected or infected monkeys after
incubation with CD178 (Fas ligand; data not shown), consistent
with earlier reports [17]. No expression of TRAIL or DR5 was
detected on lymph node pDC regardless of SIV infection status
(data not shown). These data show that pDC in lymph nodes of
monkeys with acute SIV infection are activated and have
increased death through apoptosis and necrosis, and that a
significant fraction of pDC are infected with virus.
Blood and lymph node pDC have largely normal function
in acute SIV infection
We next examined the function of pDC in blood and lymph
nodes during acute SIV infection. Given that SIV and HIV
stimulate pDC in large part through TLR7 [22,34], we analyzed
pDC function by stimulating cells with the TLR7/8 agonist 3M-
007, as in earlier experiments. We did a short-term stimulation of
unseparated PBMC taken before infection or at day 14 post
infection with 3M-007 and determined expression of TNF-a by
flow cytometry, gating on CD123+ pDC (Figure 6A). Between
20% and 40% of pDC in blood produced TNF-a in response to
TLR7 stimulation regardless of infection status (Figure 6A). We
next stimulated CD20-depleted lymph node cells taken from SIV-
naı¨ve monkeys or monkeys at 14 days post infection in the same
manner, this time analyzing cells for expression of IFN-a and
TNF-a. Approximately half of all lymph node pDC produced both
TNF-a and IFN-a in response to this stimulation regardless of
Plasmacytoid DC Loss in SIV Infection
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whether lymph nodes were taken from SIV-naı¨ve or SIV-infected
monkeys, whereas endogenous cytokine production in the absence
of stimulation was negligible (Figure 6B and data not shown).
Interestingly, the small proportion of pDC producing IFN-a alone
was undiminished by SIV infection, although lymph node pDC
from SIV-infected monkeys had a reduced capacity to produce
TNF-a alone (Figure 6B). These findings indicate that despite a
net loss of pDC the remaining cells in blood and lymph node
retained largely normal functional responses to TLR7 stimulation
during primary SIV infection.
Discussion
In this study we used rhesus macaques infected with the
pathogenic SIVmac251 strain to model kinetics of the acute pDC
response to HIV infection of humans. We combined enumeration
of cells in blood and lymphoid tissues with BrdU incorporation
and Ki-67 staining to document pDC production and trafficking.
We first confirmed that blood pDC do not cycle upon activation
and that lymph node pDC isolated during acute SIV infection are
not actively dividing, consistent with findings in the mouse [5].
Hence we were able to use markers of cell division to identify pDC
in blood and lymph node as recent emigrants from bone marrow.
Our findings reveal a rapid and highly dynamic pDC response
to SIV infection with mobilization of cells into blood occurring as
soon as 3 days after intravenous virus challenge based on absolute
pDC determinations. By 11 days after infection around 20% of
blood pDC had mobilized from bone marrow in the previous 24-
hour period as determined by BrdU incorporation, and this
reached 60% by day 14 after four administrations of BrdU. In fact
this is likely to be an underestimate of the extent of pDC
mobilization given that BrdU has a half-life of only 2 hours in the
circulation [37]. This mobilization is likely the result of increased
systemic TNF-a [38] which has been shown to control pDC
mobilization in murine models [4]. By days 10 to 14 of infection
the number of pDC in blood had dramatically declined coincident
with massive recruitment of pDC to lymph nodes, with the
proportion of lymph node pDC that had recently been released
from bone marrow being 10 to 20-fold greater than that of naı¨ve
monkeys by 14 days post infection. Rapid recruitment is consistent
Figure 4. Massive recruitment of recently mobilized pDC to peripheral lymph nodes in acute SIV infection. (A) Representative plots
demonstrating the gating strategy used to identify pDC in CD20-depleted axillary lymph nodes (left) and BrdU staining of pDC in a SIV-naı¨ve and SIV-
infected macaque (right). Numbers represent the percentage of cells within the indicated gate. (B) Percent of BrdU+ pDC in lymph nodes 24 hours
after the final BrdU pulse in naı¨ve and infected animals. Symbols represent individual animals and horizontal bars represent medians. (C)
Representative plots demonstrating Ki-67 staining in lymph node pDC as gated in (A). (D) Number of Ki-67+ pDC in lymph nodes from SIV-naive
animals and animals at day 14 post-infection expressed as a percent of all pDC (left) and as absolute number/gram of tissue (right). Symbols represent
individual animals and horizontal bars represent medians. (E) The frequency of pDC within the Lin2 HLA-DR+ gate is inversely correlated with the
percent of Ki-67+ pDC in lymph nodes. Symbols represent individual SIV-naive animals and animals at 14 days post infection.
doi:10.1371/journal.ppat.1000413.g004
Figure 3. Rapid mobilization of pDC into blood during acute SIV infection. (A) Representative contour plots from an animal prior to
infection demonstrating the gating strategy used to identify Ki-67+ pDC in blood. pDC were gated as in Figure 1 and Ki-67 positivity determined
based on the level of background fluorescence using the isotype-matched control Ab. Numbers represent the percentage of cells within the
indicated gates. (B) Paired analysis of percentage of Ki-67+ pDC in blood prior to infection and at day 14 after infection. Symbols represent individual
animals. (C) The absolute number of pDC in blood was inversely correlated with the percentage of cells expressing Ki-67. Shown are data from
individual animals prior to infection and 14 days after infection. (D) Representative contour plots demonstrating the gating strategy used to identify
BrdU+ pDC prior to and 24-hours after four consecutive intravenous daily injections of BrdU in an SIV-naive and SIV-infected macaque. BrdU was
delivered starting on day 10 of infection. Numbers represent the percentage of BrdU+ pDC within each gate. (E) The percent of BrdU+ pDC in blood of
SIV-naı¨ve animals (dashed lines) and SIV-infected animals (solid lines) 24 hours after each BrdU pulse. (F) The percent of BrdU+ pDC was positively
correlated with the percent of Ki-67+ pDC 24 hours after the final BrdU administration.
doi:10.1371/journal.ppat.1000413.g003
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Figure 5. Activation, infection, and death of pDC in SIV–infected lymph nodes. (A) Left: Contour plots demonstrating staining of lymph
node pDC from SIV-naı¨ve and SIV-infected animals with Live/Dead viability dye. Numbers represent the percentage of non-viable pDC. Right: Percent
of non-viable pDC in lymph nodes of SIV-naive animals and animals at 14 days post-infection. Symbols represent individual animals and horizontal
lines represent medians. (B) Left: Representative contour plots demonstrating staining to define early apoptotic (Annexin V+/7-AAD2) and late
apoptotic/necrotic (Annexin V+/7-AAD+) pDC from lymph nodes. Numbers represent the percent of cells in respective quadrants. Right: Percent of
late apoptotic/necrotic pDC in lymph nodes from SIV-naive animals and animals at 14 days after infection. Symbols represent individual animals and
horizontal lines represent medians. (C) Left: Representative dot plots demonstrating pDC and mDC in the Lineage2 HLA-DR+ gate prior to and after
sorting from the axillary lymph node of a monkey 14 days after infection. Numbers in parentheses indicate the purity of mDC and pDC.
Representative images of sorted mDC and pDC following modified Wright-Giemsa staining are also shown. Right: Frequency of total lymph node (LN)
cells or sorted mDC, pDC and CD4+ T cells containing proviral DNA as determined by quantitative PCR. *P,0.05, ***P,0.001. Symbols represent
individual animals and horizontal lines represent medians. (D) Left: Representative histograms demonstrating CD95 expression (solid histogram) on
pDC compared to isotype control (dotted line) in naı¨ve and SIV-infected lymph nodes. Right: Percent of lymph node pDC expressing CD95 in SIV-
naive macaques and animals with acute SIV infection. Symbols represent individual animals and horizontal lines represent medians.
doi:10.1371/journal.ppat.1000413.g005
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with TNF-a–driven expression of CXCL9 and upregulation of
CCL19 in lymph nodes [4,23,24,39] and with induction of CCR7
on activated pDC in the circulation [21,22], leading to
transmigration across high endothelial venules and localization
to the T-cell rich paracortex. These data show that the
inflammatory response in acute SIV infection is highly effective
at inducing the coordinated mobilization and recruitment of large
numbers of pDC into blood and lymph nodes.
Paradoxically, pDC recruitment was occurring as pDC
numbers in lymph nodes were dramatically declining, indicating
that cells were dying at a rate faster than they could be
replenished. Rapid influx of pDC to lymph nodes at a time when
virus is highly concentrated in these tissues [40] would increase
pDC interaction with virus-infected CD4+ T cells in the
paracortex, facilitating cell-to-cell fusion and death by apoptosis
and necrosis [17]. Consistent with this possibility, we found
around 15% of pDC undergoing late apoptosis and/or necrosis in
acutely infected lymph nodes. In addition, high virus levels in
lymph nodes would promote direct infection of pDC, and we show
using highly purified cell populations that a significant fraction of
pDC harbored proviral DNA, indicating that virus infection had
occurred and proceeded at least to the point of reverse
transcription. While the frequency of infected pDC was relatively
modest at 4% it was similar to that of CD4+ T cells, the principle
cells infected in lymph nodes at this time [41], suggesting that pDC
are a significant target of virus infection. Previous reports have
described Gag-expressing pDC in lymphoid tissues and pDC
harboring proviral DNA in blood of HIV-infected individuals
[25,26], but up to now the efficiency of pDC infection in vivo was
not known. By contrast, the frequency of infected mDC was
almost below detection, indicating that these cells may not be a
significant source of virus in lymph nodes [42]. While limited cell
numbers did not allow us to directly determine whether infection
resulted in cell death, in vitro data indicate that pDC infection
concurrent with activation through CD40L results in giant cell
formation and death [29]. In vivo, activated CD4+ T cells that
engage infected pDC in the lymph node paracortex would provide
CD40L, and Gag-expressing CD123+ multinucleated giant cells
have been identified in HIV-infected lymphoid tissues [26],
consistent with the notion of virus-induced pDC death.
Our data support the hypothesis that the physiologic response of
pDC to enter inflamed lymph nodes is actually deleterious in
pathogenic immunodeficiency virus infection as it brings pDC into
an environment rich with virus, virus-infected cells and pro-
apoptotic factors that lead to cell death. The continued loss of
pDC would disrupt normal homeostasis leading to enhanced
mobilization of cells into blood and influx into lymph nodes in an
attempt to replenish the pDC pool, exacerbating the effect.
Depletion of pDC from lymphoid tissues subsequent to recruit-
ment is likely to have a significant impact on virus control at a
number of levels. Activated pDC directly suppress HIV replication
in CD4+ T cells [17] and can stimulate antigen-specific CD4+ T
cell responses [21]. Virus-exposed pDC induce maturation of
mDC in vitro, and pDC cooperate with mDC in the induction of
virus-specific cytotoxic T cell responses in vivo [3,21]. In addition,
type I IFN production by pDC inhibits HIV replication [19].
pDC depletion from lymph nodes is found in chronically HIV-
infected individuals [43] and in advanced pathogenic SIV infection
of rhesus and pig-tailed macaques [13,14]. Our data showing
similar depletion in acute SIVmac251 infection of Indian rhesus
Figure 6. pDC retain largely normal function in response to TLR7 stimulation during acute SIV infection. (A) Left: Contour plots
demonstrating the gating strategy used to identify TNF-a+ pDC in PBMC from SIV-naı¨ve and SIV-infected monkeys following stimulation with 3M-007.
Numbers represent the percentage of TNF-a+ pDC within the indicated gates. Right: Percent of TNF-a+ pDC in PBMC from SIV-naı¨ve and SIV-infected
monkeys in response to media or 3M-007. Bars represent the median and error bars the 95% confidence interval. (B) Left: Representative contour
plots demonstrating the gating strategy used to identify TNF-a+, IFN-a+, or TNF-a+/ IFN-a+ pDC in lymph nodes following 3M-007 stimulation in the
absence or presence of Brefeldin A (BFA). Numbers in parentheses represent the percentage of cells expressing the respective cytokines. Right:
Percent of lymph node pDC from SIV-naı¨ve and SIV-infected monkeys expressing TNF-a, IFN-a, or both in response to TLR7/8 agonist. Bars represent
the median and error bars the 95% confidence interval. NS = not significant.
doi:10.1371/journal.ppat.1000413.g006
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macaques would appear to conflict with studies from other
pathogenic SIV models, including SIVsm infection in the same
species and SIVmac251 infection of Mauritius cynomolgus
macaques, which indicate that acute infection is associated with
increased numbers of pDC in lymph nodes [16,22]. In SIV-infected
cynomolgus monkeys in particular increases in pDC number in
lymph nodes were evident at 38 days and even 9 months post
infection [16]. It is interesting to note that pathogenicity of
SIVmac251 is attenuated in Mauritius cynomolgus macaques
relative to Indian rhesus macaques, associated with a more
pronounced virus-specific cellular immune response at 2 weeks
post infection [44]. It is possible therefore that enhanced immune
control of virus replication occurring in lymphoid tissues of infected
cynomolgus macaques results in reduced exposure of newly
recruited pDC to virus and virus-infected cells leading to a
reduction in pDC death. Hence the divergent response of pDC in
lymph nodes as a result of infection could potentially be an early
indicator of differential pathogenicity of SIVmac251 in these two
species. Our data raise concerns over the hypothesis that muted
pDC recruitment to lymph nodes is integral to the lack of disease in
nonpathogenic SIV infection of sooty mangabeys [22], especially
given that similar studies in nonpathogenic SIV infection of African
green monkeys reveal significant pDC influx and activation in
lymph nodes during the acute phase of infection [45].
In our study pDC from SIV-infected lymph nodes uniformly
expressed CD95, and in mice exposed to inflammatory and
microbial stimuli CD95 expression induced on activated pDC is
linked to apoptotic cell death [36]. However, while CD95/CD178
interactions play a role in CD4+ T cell loss in HIV and SIV infection
[46,47] the role for this pathway in pDC death is yet to be
established [17]. We were not able to detect TRAIL expression on
pDC isolated from lymph nodes of SIV-infected monkeys, despite
recent studies indicating that HIV induces expression of TRAIL on
pDC in an IFN-a dependent manner [48]. Serum levels of TRAIL
are increased in SIV-infected macaques as in HIV-infected humans
[49,50], and high expression of TRAIL mRNA in lymph nodes of
SIV-infected macaques is reduced by antiretroviral therapy [51].
However, TRAIL expression is not limited to pDC, as CD4+ T cells
from SIV-infected rhesus macaques express significant levels of
TRAIL as do rhesus monocytes and monocyte-derived DC exposed
to SIV in vitro [50]. More studies are needed to clarify which cell
types express TRAIL in lymphoid tissues during HIV and SIV
infection and the functional consequences of this expression.
pDC production in bone marrow was not significantly affected by
acute SIV infection in this study, although additional studies in a
larger cohort of animals are needed to confirm these findings due to
the marked variability in pDC number in aspirates. A similar wide
variation in pDC number was noted in bone marrow aspirates
analyzed from SIV-naı¨ve pig-tailed macaques [32]. No prior reports
to our knowledge have investigated the effects of SIV infection on
pDC production from bone marrow. Studies in SIV-infected
macaques indicate that virus does not infect CD34+ hematopoietic
stem cells in vivo [52], although defects in bone marrow hematopoiesis
that significantly impact upon the generation of CD4+ T cells from
CD34+ progenitors ex vivo have been demonstrated [53]. Our study
evaluated pDC kinetics in bone marrow only up to 12 days post
infection and it is possible that hematopoietic suppression may not be
occurring at this very early stage. Indeed, bone marrow suppression
as measured by a decrease in colony forming units is only evident
beginning at 21 days post infection of macaques with a pathogenic
simian/human immunodeficiency virus [54].
Reduction in circulating type I IFN has been observed in HIV-
infected individuals and is generally thought to be due to impaired
pDC function [8–10,12,55,56]. PBMC that were stimulated in vitro
with herpes simplex virus had significantly lower type I IFN in
culture supernatants when isolated from patients with primary
HIV infection relative to controls, and this was associated with
lower numbers of blood pDC [12]. In contrast, in our study pDC
from blood and lymph nodes in monkeys 14 days after
SIVmac251 infection were largely normal in their response to
TLR7 stimulation, with lymph node pDC producing TNF-a and
IFN-a together at high levels that were indistinguishable from
controls. This discrepancy may be a consequence of experiments
being performed at different stages of infection, as in the study of
primary HIV infection individuals had a median of 51 days after
the presumed date of infection [12]. Studies using intracellular
cytokine production to directly examine pDC function revealed
that markedly reduced pDC production of IFN-a was evident in
HIV-infected individuals with high virus burden and low CD4+ T
cell counts, suggesting that pDC dysfunction worsens with
advanced disease [9]. Whether IFN-a production by the limited
number of surviving pDC in acute infection is sufficient to induce
chronic CD4+ T cell activation in lymph nodes, as has recently
been proposed [22,57], remains to be determined.
While we were not able to sample mucosal tissues in the current
study, it is possible that these tissues provide a significant sink for
pDC that have been mobilized into blood in acute SIV infection,
especially given that viral replication and CD4+ T cell depletion
occur to a large extent in gut mucosa [31,58,59]. In addition,
vaginal SIV infection rapidly induces a local inflammatory
response with pronounced type I IFN production [40,60], and
similar responses occurring subsequent to mucosal viral infection
in the mouse are associated with pDC recruitment and activation
that suppresses virus replication [61]. The relationship between
pDC and mucosa in the context of SIV infection is likely to be
important in disease pathogenesis and needs to be addressed.
Materials and Methods
Animals, virus infection, and sample collection
Six adult female Indian-origin rhesus macaques (Macaca mulatta)
were infected by intravenous inoculation with 1,000 TCID50
SIVmac251 that had been grown in CEMx174 cells [62] (kindly
provided by Preston Marx, Tulane National Primate Research
Center) and compared to a cohort of six SIV-naive controls. Blood
samples were collected in either EDTA or ACD four to six times
prior to infection including day 0 and on days 3, 6, 10, 11, 12, 13
and 14 post-infection. BrdU (Sigma) was prepared in Ca2+/Mg2+-
free HBSS at 10 mg/ml, filter-sterilized and administered by
intravenous injection at 30 mg/kg at 24-hour intervals for 4 doses
starting on day 10 post-infection. Parallel BrdU administration was
given to two SIV-naı¨ve monkeys. Bone marrow aspirates were
obtained at least 30 days prior to and on day 12 post-SIV infection
from the medullary cavity of alternating femurs using a Jamshidi
bone marrow biopsy needle flushed with heparin. SIV-infected
animals were sacrificed on day 14 post-infection and the two SIV-
naive animals receiving BrdU were sacrificed 24 hour after the final
drug dose. All animals underwent transcardiac saline perfusion at
the time of sacrifice to ensure removal of peripheral blood from
tissues. All experiments were performed using protocols approved
by appropriate institutional regulatory committees.
Sample processing
PBMC were isolated by density gradient centrifugation over
Ficoll. Alternatively, blood samples were lysed of red blood cells
using ACK lysing buffer for isolation of PBL. Lymph node single-
cell suspensions were generated and depleted of CD20+ B cells as
previously described [13]. Bone marrow aspirates were passed
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over a 70 mm nylon cell strainer to remove spicules and diluted 1:1
with PBS prior to erythrocyte lysis and counting using trypan blue
exclusion. All blood, lymph node and bone marrow preparations
were frozen in medium containing 90% FBS and 10% DMSO
(Sigma) using a controlled-rate freezer (CryoMed) and stored in
liquid nitrogen. Viral RNA levels in plasma were determined by
real-time PCR using an ABI Prism 7900H sequence detection
system (Applied Biosystems) using reverse-transcribed viral RNA
as templates, as described [63].
Flow cytometry, cell enumeration, and cytokine
expression
All antibodies were purchased from BD Biosciences unless noted
otherwise. For the majority of analyses cells were stained with
antibodies to Lineage markers [CD3 (clone SP34-2), CD14 (M5E2),
and CD20 (2H7, eBioscience)], CD45 (D058-1283), HLA-DR
(G46-6), and CD123 (7G3) with or without an amine-reactive Live/
Dead cell viability dye (Invitrogen) using mutually-exclusive
fluorochrome conjugates. In some experiments cells were co-stained
with Ab to CD95 (DX2) or with 5.0 mg/mL 7-AAD and Annexin V
(BD Biosciences). Alternatively, labeled cells were fixed and
permeabilized with Cytofix/Cytoperm (BD Biosciences) and
incubated with Ab to Ki-67 (B56). To detect in vivo BrdU
incorporation labeled cells were fixed with 4% formaldehyde prior
to incubation with DNase I (Roche) in 0.1% saponin and incubation
with antibody to BrdU (B44). In some experiments PBMC and
lymph node cells were pulsed with 10 mM BrdU ex vivo for 4 hours
prior to staining with antibody to BrdU as per manufacturer’s
instructions (BrdU Flow Kit, BD Pharmingen). Absolute numbers of
cells were determined using a modified single-platform quantifica-
tion assay as described [30]. Briefly, the number of CD45+
mononuclear cells and CD4+ T cells in blood were determined by
staining 50 mL of whole blood with antibodies to CD3, CD4 (L200)
and CD45 using TruCOUNT tubes (BD Biosciences) as per the
manufacturer’s recommendations. For pDC quantification PBL
were stained with antibodies to define pDC, and the absolute
number of pDC/mL blood was then calculated by multiplying the
percentage of pDC within the CD45+ fraction by the absolute
number of CD45+ cells calculated using whole blood in
TruCOUNT tubes. A similar method was used to calculate
mononuclear cells and pDC in bone marrow aspirates. For analysis
of intracellular cytokine expression, PBMC were stimulated for
5 hours in media alone or with 10 mM of the TLR7/8 agonist 3M-
007 (3M Pharmaceuticals) in the presence of 10 mg/mL brefeldin A
(Sigma) for the final 3 hours. Alternatively, CD20-depleted lymph
node cells were stimulated for 12 hours for convenience with 10 mM
3M-007 agonist in the presence or absence of 10 mg/mL brefeldin A
included after 1 hour. Cells were stained with surface-labeling
antibodies and fixed and permeabilized as above prior to incubation
with antibodies to TNF-a (MAb11) and/or IFN- a (MMHA-2, PBL
Biomedical Laboratories). Ab to IFN- awas conjugated to Alexa 647
using Zenon labeling technology according to the manufacturer’s
protocol (Invitrogen). In some experiments PBMC were stimulated
with 10 mM 3M-007 in the presence of 20 ng/ml recombinant
human IL-3 (R&D Systems) for 20 hours prior to pulsing with BrdU
as above. Flow cytometry data was acquired using a BD LSR II or
FACS Aria flow cytometer and analyzed with BD FACS Diva
software (version 5.0.2) and histogram overlays generated using
FlowJo version 7.2.4 (Tree Star, Inc.).
Cell sorting
Previously cryopreserved lymph node cell suspensions were
thawed in the presence of DNAse, strained and then stained with
antibodies to Lineage markers, HLA-DR, CD123 and CD11c (S-
HCL-3) along with the Live/Dead viability dye. Between 5,000
and 10,000 viable Lin2 HLA-DR+ CD123+ CD11c2 pDC and
Lin2 HLA-DR++ CD1232 CD11c+ mDC were sorted simulta-
neously using a BD FacsAria flow cytometer, making sure to
exclude doublets on the basis of forward scatter and side scatter
height and width parameters. In these sorting experiments we used
a broad Lineage2 HLA-DR+/++ gate to encompass both DC
subsets as described previously [13]. For purification of CD4+ T
cells, lymph node suspensions were stained with antibodies to
CD3, CD4 and CD8 (B9.11, Immunotech) and 50,000 viable
CD3+CD4+CD82 cells sorted as above. Purified cells were
deposited into tubes containing lysis buffer for DNA isolation or
into tubes containing media followed by centrifugation onto slides
(Cytospin 3, Shandon). Slides were fixed and stained using a
modified Wright-Giemsa stain (Hema 3, Fisher) and imaged using
an Olympus BX51 light microscope.
Quantification of SIV proviral DNA
Cellular DNA from sorted cells was isolated using DNAeasy blood
and tissue kit (Qiagen). For quantitative PCR analysis, a plasmid was
first generated by inserting sequences of SIVsmB7 long terminal
repeat and SIVmac239 gag in the pUC19 plasmid along with
macaque albumin cDNA. This plasmid was validated against serial
dilutions of B7 cells containing a single integrated copy of SIVsmB7
[64] by using TaqMan real-time PCR with primers 59-TTG-
AGCCCTGGGAGGTTCT-39 and 59-CCAAGTGCTGGTGA-
GAGTCTAG-39, and probe 59-CAGCACTAGCAGGTAGAG-
CCTGGGTGTTC-39, and used as a standard for calculating the
frequency of infection in sorted cells. SIVmac251 gag copy number in
each DNA sample was quantified by comparison with serial dilutions
of the plasmid standard using TaqMan real-time PCR using primers
59-GCCAGGATTTCAGGCACTGT-39 and 59-GCTTGATGG-
TCTCCCACACAA-39, and the probe 59-AAGGTTGCACCCCC-
TATGACATTAATCAGATGTTA-39 specific for sequences of gag
that are conserved across SIV strains. In parallel, the albumin gene
copy number was determined to quantify the number of cells loaded
in each reaction using primers 59-TGCATGAGAAAACGC-
CAGTA-39 and 59-AGCATGGTCGCCTGTTCAC-39 and probe
59-AAAGTCACCAAATGCTGCACGGAATCC-39. Reactions
were performed in duplicate using TaqMan Universal mix kit
(Applied Biosystems), 200 nM of each primer and 125 nM probe, at
95uC for 10 minutes, with 40 cycles at 95uC for 15 seconds and at
60uC for 1 minute using the Prism 7900H sequence detection system
(Applied Biosystems).
Statistical analysis
Differences between pre and post-infection time points were
determined using the nonparametric Wilcoxon signed-rank test.
Cross-sectional analysis of SIV-naı¨ve and animals with acute SIV
infection were performed using the nonparametric Mann-Whitney
U test. Correlations were determined using the non-parametric
Spearman rank test. Multiple comparisons between the frequen-
cies of SIV infection in sorted populations were performed using
the Kruskal-Wallis test followed by Dunn’s post test. All statistical
comparisons were considered significant when two-tailed P,0.05.
Supporting Information
Figure S1 Intravenous inoculation with SIVmac251 produces
high plasma virus load and blood CD4+ T cell loss.
Found at: doi:10.1371/journal.ppat.1000413.s001 (0.12 MB PDF)
Figure S2 Rhesus macaque pDC from blood and lymph node
fail to proliferate following ex vivo activation or in vivo SIV infection.
Found at: doi:10.1371/journal.ppat.1000413.s002 (0.10 MB PDF)
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